Abstract
Operating room teams at three U.S. hospitals are participating in a controlled clinical trial to evaluate the use of a surgical robot in total hip arthroplasty. The robot, called the ROBODOC Surgical Assistant System, precisely prepares the femoral canal for the placement of a "press fit" cementless prosthesis. The Food and Drug Administration (FDA) requires that the robot, as an investigational device, be tested in a controlled clinical trial to demonstrate safety and efficacy. The clinical trial will include 300 patients who must meet specific criteria before enrollment and randomization. This article describes the need for new surgical technology, ROBODOC's development history, hardware and software components of the system, the patient population and surgical protocol for the clinical trial, special nursing care requirements, and considerations for patient rehabilitation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
